THC gummies in Switzerland: the Zurich pilot study

20/05/2024
THC infused gummies

THC edibles are not legally sold in Switzerland. The exception is the Zurich pilot study run by Swiss Cannabis Research with the University of Zurich and ETH’s KOF: registered adult participants can buy THC wine gums and pralines, with up to 10 mg THC per piece, at pilot shops and pharmacies. A national cannabis law is still being drafted.

Are THC edibles legal in Switzerland?

THC edibles are not legally for sale in Switzerland. The only exception is the canton of Zurich’s cannabis pilot study, which in 2024 began offering THC wine gums and pralines to registered adult participants.

This initiative is part of the largest cannabis study in Switzerland, launched by the Swiss Cannabis Research association in collaboration with the University of Zurich and the KOF/ETH.

Where the edibles are sold

Participants buy the products in specialist shops and pharmacies in the canton of Zurich. To buy them, you must first register as a participant in the Swiss Cannabis Research study, which started sales in May 2024 and runs for five years. The study aims to include up to 7,500 participants, making it the largest of its kind in Switzerland.

Study requirements and product details

Participants have access to two types of THC-infused sweets: wine gums and pralines. Each piece contains a maximum of ten milligrams of THC. Prices are set deliberately high to discourage excessive consumption.

The Swiss Cannabis Research association, headed by President Paul-Lukas Good, is focused on producing these edibles domestically with approval from the Federal Office of Public Health (BAG).

Good emphasises that the study participants have consistently requested edibles, and this initiative responds to their demand while aligning with the study's goals to evaluate the economic and health impacts of cannabis regulation.

How the study is designed

The study also wants to offer ways to consume THC without tobacco. Participants are split into three groups, and one of them is a control group that does not get access to the regulated products (swissinfo). The results will feed into the debate on how Switzerland should regulate cannabis.

Switzerland’s proposed law for regulated cannabis

In February 2025, the National Council’s Social Security and Health Committee (SGK-N) adopted a preliminary draft law that would permit adults to access cannabis through a regulated, state-controlled framework without a profit motive:

  • Cannabis products would be available exclusively at a select number of licensed physical stores and a single state-approved online retailer.
  • Any profits from sales would have to be invested in prevention, harm reduction and addiction support, while revenue from a proposed steering tax on cannabis products would be redistributed through health insurance.
  • Before the law can be enacted, the draft must go through a public consultation, and the issue could be put to a national referendum.

The draft went to public consultation in autumn 2025 (Federal Office of Public Health). On 8 May 2026, after reviewing the responses, the committee voted 16 to 8 to continue the work but sent the draft back to its subcommittee for revision (Swiss Parliament). The committee noted that most cantons rejected the draft in its current form.

As of September 2026, the cultivation, manufacture, trade and use of cannabis for non-medical purposes are still prohibited in Switzerland, outside the pilot studies. This applies to cannabis with a THC content of 1% or more; products with less than 1% THC, such as many CBD products, are not covered by the Narcotics Act, although other rules, for example on food or product safety, may apply. Since 2023, select pilot programmes have permitted limited legal access to cannabis for specific groups.

Our guide to CBD and drug tests explains whether trace amounts of THC in CBD oil can show up in a test.

Our view

Formula Swiss has been based in Switzerland since 2013 and produces its oils in Küssnacht am Rigi. As a Swiss hemp company, we follow the pilot trials because their data will shape the future law, including how low-THC hemp products are treated.

Frequently asked questions

Are THC gummies legal in Switzerland?

No. Edibles with 1% THC or more are illegal in Switzerland outside medical use. The only legal exception is the Zurich pilot study, where registered adult participants can buy THC wine gums and pralines with up to 10 mg THC per piece.

Who can buy edibles in the Zurich study?

Only people who have registered as participants in the Swiss Cannabis Research study and are assigned to a group with access to the products. The study aims to include up to 7,500 participants and runs for five years.

Is CBD legal in Switzerland?

Products with less than 1% THC, such as many CBD products, are not covered by the Swiss Narcotics Act, although other rules, for example on food or product safety, may apply.

Will Switzerland legalise cannabis?

A parliamentary committee adopted a draft law for regulated, non-profit cannabis sales in February 2025. After a public consultation, the committee sent it back to its subcommittee for revision in May 2026. The law still needs both chambers of parliament and could face a referendum.

This article is for information only and does not describe any product in our shop. Formula Swiss oils are cosmetics for external use. See our full disclaimer.

Last reviewed:

Sources

  1. swissinfo.ch (2024). Switzerland’s largest cannabis study starts in canton Zurich. www.swissinfo.ch/eng/life-aging/switzerlands-largest-cannabi
  2. Swiss Parliament, SGK-N press release (14 February 2025). Preliminary draft on the regulation of the cannabis market. www.parlament.ch/press-releases/Pages/mm-sgk-n-2025-02-14.as
  3. Federal Office of Public Health. Neues Cannabisproduktegesetz (new cannabis products act). www.bag.admin.ch/de/neues-cannabisproduktegesetz
  4. Swiss Parliament, SGK-N press release (8 May 2026). Cannabis products act sent back to the subcommittee for revision. www.parlament.ch/press-releases/Pages/mm-sgk-n-2026-05-08.as
Back to blog

Leave a comment

Please note, comments need to be approved before they are published.

Robin Roy Krigslund-Hansen

Robin Roy Krigslund-Hansen

About the author

Robin Roy Krigslund-Hansen is the co-founder and CEO of Formula Swiss and is responsible for formulation. Since co-founding the company in 2013, he has written about hemp, CBD, and the cannabis industry. His perspective draws on building Formula Swiss, conversations with researchers, and supporting CBD research.

More about Robin Roy Krigslund-Hansen

How we write and check our guides

Related products